Literature DB >> 12479821

Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.

Thomas M Schmitt1, Juan Carlos Zúñiga-Pflücker.   

Abstract

The molecular interactions provided by the thymic microenvironment that predicate T cell development remain obscure. Here, we show that a bone marrow stromal cell line ectopically expressing the Notch ligand Delta-like-1 loses its ability to support B cell lymphopoiesis, but acquires the capacity to induce the differentiation of hematopoietic progenitors into CD4 CD8 double- and single-positive T cells. Both gammadelta-TCR(+) and alphabeta-TCR(+) T cells are generated, and CD8(+) TCR(hi) cells produce gamma-interferon following CD3/TCR stimulation. These results establish that expression of Delta-like-1 on stromal cells provides key signals for the induction of T cell lineage commitment, stage-specific progenitor expansion, TCR gene rearrangement, and T cell differentiation in the absence of a thymus. Thus, it is likely that Delta-like-1/Notch interactions by the thymus underpin its unique ability to promote lineage commitment and differentiation of T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12479821     DOI: 10.1016/s1074-7613(02)00474-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  446 in total

1.  A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Authors:  Sheng Zhou; Disha Mody; Suk See DeRavin; Julia Hauer; Taihe Lu; Zhijun Ma; Salima Hacein-Bey Abina; John T Gray; Michael R Greene; Marina Cavazzana-Calvo; Harry L Malech; Brian P Sorrentino
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

2.  Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation.

Authors:  Mi Cai; Ellen M Langer; Jennifer G Gill; Ansuman T Satpathy; Jörn C Albring; Wumesh KC; Theresa L Murphy; Kenneth M Murphy
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

3.  Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.

Authors:  Korashon L Watts; Colleen Delaney; R Keith Humphries; Irwin D Bernstein; Hans-Peter Kiem
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

Review 4.  Factors and networks that underpin early hematopoiesis.

Authors:  Elinore M Mercer; Yin C Lin; Cornelis Murre
Journal:  Semin Immunol       Date:  2011-09-18       Impact factor: 11.130

5.  Identification of the earliest natural killer cell-committed progenitor in murine bone marrow.

Authors:  John W Fathman; Deepta Bhattacharya; Matthew A Inlay; Jun Seita; Holger Karsunky; Irving L Weissman
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

6.  Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.

Authors:  Colleen M Witt; Vincent Hurez; C Scott Swindle; Yoshio Hamada; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  Fates and potentials of thymus-seeding progenitors.

Authors:  Rhodri Ceredig
Journal:  Nat Immunol       Date:  2012-03-19       Impact factor: 25.606

Review 8.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture.

Authors:  Génève Awong; Jastaranpreet Singh; Mahmood Mohtashami; Maria Malm; Ross N La Motte-Mohs; Patricia M Benveniste; Pablo Serra; Elaine Herer; Marcel R van den Brink; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2013-11-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.